September 28th ICOC/ARS Meeting

Return to CIRM Meetings and Events

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS OVERSIGHT COMMITTEE AND
THE APPLICATION REVIEW SUBCOMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Date: September 28, 2023

Time: 9:00 am to 4:00 pm

Location: The Embassy Suites

250 Gateway Blvd, Pauling Room

South San Francisco, CA 94080

 

This meeting of the Independent Citizens Oversight Committee and the Application Review Subcommittee will be conducted in person and via teleconference option listed below, which will be made accessible to the public.  Members of the public may attend this meeting in person at the address printed above or remotely via the options listed below.

 

Public Comment Instructions

 

Members of the public who are listening to the meeting and wish to make a comment will have the opportunity to do so by doing the following:  

• Once we have called for public comment, members of the public will be able to do so by pressing *9 which will place you in a queue to make your comment
• Once we call your name you will have 3 Minutes to make your public comment; please remember to be respectful of the time limit.
• Written comment may be sent to the following email address: lmoralez@cirm.ca.gov.

YouTube: www.youtube.com/cirmtv

 

Dial-In information:

Dial in number: (669) 900-6833

Meeting ID: 861 7815 7403
Passcode: 230928

 

Open Session

1. Call to Order
2. Roll Call

Consent Calendar

3. Consideration of minutes from November 29, 2022; June 29, 2023 ICOC & Application Review Subcommittee Meeting; and July 27, 2023 Application Review Subcommittee Meeting
4. Consideration of appointment of Facilities Working Group members and appointment of Facilities Working Group Chair
5. Consideration of appointment of members to the Access and Affordability Working Group
6. Consideration of appointment of members to the Grants Working Group
7. Consideration of appointment of Chair of the Finance Subcommittee of the ICOC
8. Consideration of amendments to the Grants Working Group Bylaws
   • Memo
   • Letter to the Board

Closed Session

9. Discussion of Personnel [Evaluation of CIRM President/CEO] (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(f) (3) (D))
   • Letter to the Board
10. Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to applications submitted in response to agenda items 11, 12 and 13 (Health & Safety Code 125290.30(f) (3) (B) and (C))

Open Session

11. Consideration of applications submitted in response to Clinical Trial Stage Projects Program Announcement (CLIN 1 or 2)
    • Presentation
12. Consideration of applications submitted in response to DISC2 23.1 Quest Program Announcement
    • Presentation (updated 09/20/23)
    • Letter to the Board – DISC2-14900
    • Letter to the Board – DISC2-15114
13. Consideration of applications resubmitted in response to INFR5: California Cell and Gene Therapy Manufacturing Network Program Announcement
    • Presentation
14. Consideration of proposed ReMIND Concept Plan for Neuropsychiatric Disease
    • Memo
    • Presentation
15. Consideration of EDUC4 Research Training Awards – Budgetary Supplement (updated 09/28/23)
    • Presentation (updated 09/28/23)
16. Chairman’s Report
17. President’s Report
18. General Comments on ARS Process
19. Public comment
20. Adjournment

 

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Lana Moralez at the California Institute for Regenerative Medicine at 510-340-9101 no later than the day prior to the meeting.

---